Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind double-dummy study of SHR8008 capsules versus fluconazole for recurrent vulvovaginal candidiasis
CTR20211991Phase 3Suspended
- Sponsor
- Patheon
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oteseconazole in recurrent vulvovaginal candidiasis (RVVC), sponsored by Patheon. Started Sep 2021; status: suspended.
02
Drugs
oteseconazole
03
Conditions
recurrent vulvovaginal candidiasis (RVVC)
Beyond the preview
Go deeper on CTR20211991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211991.